Kobayashi Taira
Department of Cardiovascular Surgery, JA Hiroshima General Hospital, Japan.
Interv Radiol (Higashimatsuyama). 2025 Feb 7;10:e20240043. doi: 10.22575/interventionalradiology.2024-0043. eCollection 2025 Mar 28.
Endovascular treatment for patients with lower extremity artery disease is conducted worldwide due to its efficacy. Many studies have shown durability for patients with intermittent claudication, and various guidelines have shifted to the use of endovascular treatment. However, clinical outcomes in patients with chronic limb-threatening ischemia who undergo endovascular treatment have not been fully investigated. Generally, chronic limb-threatening ischemia cases have complex lesions such as small vessels, severe calcification, poor runoff vessels, chronic total occlusion, and long lesions, which result in poor outcomes. Thus, endovascular treatment for chronic limb-threatening ischemia cases remains challenging, despite the many technical and device advances. In 2019, the Global Vascular Guidelines were proposed for the treatment of patients with chronic limb-threatening ischemia. Here, we review previous guidelines and reports of patients with lower extremity artery disease who underwent endovascular treatment.
由于其有效性,下肢动脉疾病患者的血管内治疗在全球范围内开展。许多研究表明,间歇性跛行患者接受该治疗后效果持久,各种指南也已转向采用血管内治疗。然而,接受血管内治疗的慢性肢体威胁性缺血患者的临床结局尚未得到充分研究。一般来说,慢性肢体威胁性缺血病例存在复杂病变,如小血管、严重钙化、流出道血管不佳、慢性完全闭塞和长病变,这些都会导致预后不良。因此,尽管有许多技术和设备进展,慢性肢体威胁性缺血病例的血管内治疗仍然具有挑战性。2019年,针对慢性肢体威胁性缺血患者的治疗提出了《全球血管指南》。在此,我们回顾先前关于接受血管内治疗的下肢动脉疾病患者的指南和报告。